Skip to Content

RF Microneedling: Pilot Study Finds an Aftercare Benefit

The biosome aftercare tested performed better than the control aftercare at 60 days. That is not enough to support a general recommendation.
November 21, 2026 by
RF Microneedling: Pilot Study Finds an Aftercare Benefit
Maria Petrenko

A pilot study in Biomedicines found a benefit for biosome aftercare following facial RF microneedling. After 60 days, the evaluators rated the improvement in skin appearance higher in the biosome group than in the placebo group. The study was published on November 20, 2026. Twenty-five participants completed the study through day 60.

What the Pilot Study Compared and Measured

A practitioner examines two unlabeled skincare containers next to an RF microneedling handpiece.

Immediately after the facial treatment, participants were randomly assigned to receive one of two aftercare products: one containing biosomes or a placebo. Biosomes are tiny fat particles that carry proteins. The evaluators did not know which aftercare product each participant had received.

For people considering RF microneedling as an option, this distinction matters: the study compared aftercare products. It did not compare the treatment itself with other procedures.

The evaluators used the Global Aesthetic Improvement Scale (GAIS) to rate the overall improvement in skin appearance. Separately, the team collected skin images and participant feedback and recorded how well the aftercare was tolerated.

In separate lab experiments, the team examined how skin cells and skin models responded to biosomes. These experiments do not show how much the aftercare benefits people after treatment.

What the Day 60 Result Means

An editor compares two sheets of paper with illegible notes on a desk.

The difference between the groups on the rating scale was statistically significant (p = 0.0193). However, the study abstract does not say how far apart the scores were. The p-value alone does not tell you how noticeable the difference would be in the mirror.

It remains unclear whether redness subsided faster. For redness and other skin characteristics, the team reports only trends, not a confirmed benefit.

According to the study abstract, no treatment-related adverse events were reported. With so few participants, however, rare side effects cannot be ruled out.

The pilot study offers preliminary evidence of a benefit for the specific aftercare product tested. It remains unclear whether similar products offer the same benefit. During a consultation, it is therefore worth asking what aftercare is planned and what the recommendation is based on.

Separately from the study, Mary4Beauty provides information about its services for cosmetic microneedling.

Sources: Biological Characterization and Pilot Clinical Evaluation of Growth Factor-Loaded Biosomes for Skin Regeneration

RF Microneedling: Pilot Study Finds an Aftercare Benefit
Maria Petrenko November 21, 2026
Share this post
Temu: EU criticizes product checks, including those for cosmetics
The European Commission says Temu does not prioritize cosmetics in its physical checks. Temu disputes the preliminary assessment.